You can find the annual or quarterly income statement of Transcode Therapeutics Inc here for insights into the performance and operational efficiency of Transcode Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Operating expenses

110.78%4.54M

-20.46%4.07M

-13.45%2.82M

14.28%4.61M

-59.24%2.15M

17.78%5.11M

-32.35%3.26M

-21.13%4.03M

22.90%5.28M

-7.08%4.34M

38.93%4.82M

82.78%5.11M

84.63%4.30M

1465.47%4.67M

672.14%3.47M

--2.80M

--2.33M

--298.48K

--449.46K

R&D expenses

157.54%3.16M

-16.73%2.57M

26.18%2.22M

8.17%3.64M

-63.28%1.23M

3.90%3.08M

-32.12%1.76M

25.19%3.36M

9.81%3.34M

13.20%2.97M

37.72%2.59M

109.00%2.69M

206.56%3.04M

1137.31%2.62M

613.37%1.88M

--1.29M

--992.95K

--211.75K

--263.76K

Depreciation, depletion, and amortization

-96.25%4.78K

-90.59%13.44K

-63.87%51.17K

-12.35%122.86K

-8.11%127.52K

3.81%142.83K

41.37%141.65K

375.08%140.17K

459.56%138.78K

506.18%137.59K

363.86%100.20K

1.78%29.50K

229.16%24.80K

--22.70K

--21.60K

--28.99K

--7.54K

----

Other operating expenses

-85.51%-22.17K

---153.69K

-1185.60%-347.84K

-1680.08%-485.05K

56.44%-11.95K

100.00%0.00

65.93%-27.06K

92.90%-27.25K

95.81%-27.44K

-2171.63%-788.94K

-1036.04%-79.41K

-102.47%-383.77K

-1963.81%-654.95K

39.12%-34.73K

---6.99K

---189.55K

---31.73K

---57.05K

--0.00

Operating profit

-110.78%-4.54M

20.46%-4.07M

13.45%-2.82M

-14.28%-4.61M

59.24%-2.15M

-17.78%-5.11M

32.35%-3.26M

21.13%-4.03M

-22.90%-5.28M

7.08%-4.34M

-38.93%-4.82M

-82.78%-5.11M

-84.63%-4.30M

-1465.47%-4.67M

-672.14%-3.47M

---2.80M

---2.33M

---298.48K

---449.46K

Net non-operating interest income (expenses)

Non-operating interest income

-17.88%147.00

-16.85%148.00

-13.10%146.00

16.06%159.00

36.64%179.00

-27.64%178.00

-96.48%168.00

-98.58%137.00

-98.54%131.00

-81.52%246.00

979.19%4.77K

1789.41%9.64K

6283.69%9.00K

133000.00%1.33K

3583.33%442.00

--510.00

--141.00

--1.00

--12.00

Non-operating interest expense

-44.77%5.96K

----

-98.83%114.00

-96.72%1.83K

-37.55%10.79K

--4.48K

--9.71K

74.76%55.90K

--17.28K

----

--31.99K

-100.00%0.00

--0.00

--333.00

--41.97K

--52.77K

Gains from sale of securities

79.63%-32.05K

34.59%-47.49K

50.88%-27.19K

--228.20K

---157.31K

---72.59K

---55.35K

----

Special income (expenses)

---279.16K

---161.71K

---9.23M

---938.69K

----

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---1.34K

--3.11M

---3.98M

- Gains from disposal of fixed assets

----

--500.00

----

---3.08K

----

Other non-operating income (expenses)

----

---596.96K

----

Income before tax

-109.19%-4.86M

17.61%-4.28M

-263.27%-12.09M

-44.73%-5.92M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

---2.80M

---2.33M

--2.77M

---4.49M

Income tax

----

--0.00

----

--0.00

Income after tax

-109.19%-4.86M

17.61%-4.28M

-263.27%-12.09M

-44.73%-5.92M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

---2.80M

---2.33M

--2.77M

---4.49M

Net income from continuous operations

-109.19%-4.86M

17.61%-4.28M

-263.27%-12.09M

-44.73%-5.92M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

---2.80M

---2.33M

--2.77M

---4.49M

Net income attributable to controlling interests

-109.19%-4.86M

17.61%-4.28M

-263.27%-12.09M

-45.48%-5.95M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

---2.80M

---2.33M

--2.77M

---4.49M

Preferred share dividend

----

--30.60K

----

Net income attributable to common shareholders

-109.19%-4.86M

17.61%-4.28M

-263.27%-12.09M

-45.48%-5.95M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

-268.58%-4.67M

22.64%-3.47M

---2.80M

---2.33M

--2.77M

---4.49M

Basic earnings per share

96.01%-5.82

99.25%-5.13

88.26%-70.16

95.75%-272.98

99.67%-146.07

99.44%-680.22

99.76%-597.77

97.80%-6.42K

81.68%-44.76K

54.30%-121.61K

-25.09%-247.26K

-82.36%-292.41K

-63.54%-244.34K

-160.23%-266.08K

72.36%-197.66K

---160.35K

---149.41K

--441.79K

---715.15K

Diluted earnings per share

96.01%-5.82

99.25%-5.13

88.26%-70.16

95.75%-272.98

99.67%-146.07

99.44%-680.22

99.76%-597.77

97.80%-6.42K

81.68%-44.76K

54.30%-121.61K

-25.09%-247.26K

-82.36%-292.41K

-63.54%-244.34K

-170.15%-266.08K

72.36%-197.66K

---160.35K

---149.41K

--379.29K

---715.15K

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

